Skip to main content

Precautions Needed When Folks Taking Ozempic, Wegovy Undergo Anesthesia

Medically reviewed by Carmen Pope, BPharm. Last updated on March 13, 2024.

By Carole Tanzer Miller HealthDay Reporter

WEDNESDAY, March 13, 2024 — Nurses who specialize in anesthesia have issued new guidelines to reduce the risk that patients taking weight-loss drugs like Ozempic or Wegovy throw up during surgery.

"These medications have exploded in popularity," said Micah Walden, of the American Association of Nurse Anesthesiology (AANA) Practice Committee. "This means additional preparation for patients, anesthesia providers and the surgical team to help minimize risks of complications during a procedure."

Because general anesthesia can cause nausea, patients are usually asked to fast before surgery. But a study published last week in the journal JAMA Surgery found these weight-loss drugs — called GLP-1 receptor agonists — slow digestion, so it takes longer for food to leave the stomach. That increases a patient's risk of vomiting or aspiration while under anesthesia.

GLP-1 agonists like Ozempic, Wegovy (semaglutide), Saxenda (liraglutide) or Zepbound (tirzepatide) were originally designed to manage type 2 diabetes, but they have become a popular way to lose weight. They make patients feel full sooner, so they eat less.

As a precaution, the AANA committee said providers may need to do extra screenings such as an ultrasound of the patient's stomach before surgery. If the examination indicates that the stomach is not empty or the imaging is inconclusive, the surgical team may consider delaying an elective surgery or proceeding as "full stomach" to reduce the risk of vomiting and aspiration while the patient is intubated for anesthesia care, the committee said.

As they developed their recommendations, members of the practice committee said they considered the length of time various GLP-1 medications continue to affect patients.

They recommend withholding medication for a week before surgery if patients take a weekly dose. Those on a daily dose should not use the medication on the day of procedure, the recommendations advise.

The recommendations were published March 12.

"Open communication between patients and the surgical team is important to recommendations for withholding GLP-1 agonist medications prior to surgery," Walden said in an AANA news release. "As providers, we take that information into account to perform an individualized, case-by-case assessment and create a care plan that will keep the patient safe and comfortable before, during and after the procedure."

Sources

  • American Association of Nurse Anesthesiology, news release, March 12, 2024

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted March 2024

Read this next

Ozempic Lowers Odds for Death, Illness in People With Kidney Disease and Type 2 Diabetes

FRIDAY, May 24, 2024 -- Ozempic provides a wide variety of health benefits for people with kidney disease and type 2 diabetes, a major clinical trial has found. The drug...

Costs, Side Effects Drive Folks to Quit New Weight-Loss Meds

THURSDAY, May 23, 2024 -- Three months after starting one of the new GLP-1 weight-loss drugs, more than a quarter of patients have already quit the medications, and by a year from...

Use of GLP-1 Meds Have Risen 7-Fold Among Young Americans

WEDNESDAY, May 22, 2024 -- The number of American teens and young adults who've been prescribed one of the new GLP-1 weight-loss drugs soared nearly seven-fold between 2020 and...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.